Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Cited by (1,001)

Items 601–700 of 1,001

1. An Upstream YY1 Binding Site on the HIV-1 LTR Contributes to Latent Infection
   Wendy Bernhard, Kris Barreto, Sheetal A. Raithatha, Ivan Sadowski · 2013 · PLoS ONE
2. HIV-1 Integrase: From Biology to Chemotherapeutics
   Eriketi Z. Loizidou, Christos A. Nicolaou, Athanassios V. Nicolaides, Leondios G. Kostrikis · 2007 · Current HIV Research
3. HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
   Julia Sung, David M. Margolis · 2018 · Advances in experimental medicine and biology
4. Evolutionary Dynamics of HIV-1 and the Control of AIDS
   James I. Mullins, Mark A. Jensen · 2006 · Springer eBooks
5. Nanodrug Formulations to Enhance HIV Drug Exposure in Lymphoid Tissues and Cells: Clinical Significance and Potential Impact on Treatment and Eradication of HIV/AIDS
   Jingwei Shao, John C Kraft, Bowen Li, Jesse Yu, Jennifer P. Freeling, Josefin Koehn, Rodney J. Y. Ho · 2016 · Nanomedicine
6. HIV-1 Latency and Eradication: Past, Present and Future
   Prasun K. Datta, Rafal Kaminski, Wenhui Hu, Vanessa Pirrone, Neil T. Sullivan, Michael R. Nonnemacher, Will Dampier, Brian L. Wigdahl, Kamel Khalili · 2016 · Current HIV Research
7. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy
   Duncan Chege, Colin M Kovacs, Charles la Porte, Mario Ostrowski, Janet Raboud, DeSheng Su, Gabor P. Kandel, Jason M. Brunetta, Connie J. Kim, Prameet M. Sheth et al. · 2011 · AIDS
8. CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA
   Caroline S. Binda, Bep Klaver, Ben Berkhout, Atze T. Das · 2020 · Viruses
9. Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity
   Mehdi Shafiee Ardestani, Alireza Salehi Fordoei, Asghar Abdoli, Reza Ahangari Cohan, Golnaz Bahramali, Seyed Mehdi Sadat, Seyed Davar Siadat, Hamid Moloudian, Nasser Nassiri Koopaei, Azam Bolhassani et al. · 2015 · Journal of Materials Science Materials in Medicine
10. In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation
    Jessica M. Brogdon, Widade Ziani, Xiaolei Wang, Ronald S. Veazey, Huanbin Xu · 2016 · Scientific Reports
11. HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients
    Jonathan L. Golob, Joshua Stern, Sarah Holte, Mari M. Kitahata, Heidi M. Crane, Robert W. Coombs, Erin A. Goecker, Ann E. Woolfrey, Robert D. Harrington · 2018 · AIDS
12. HUSH, a Link Between Intrinsic Immunity and HIV Latency
    Ghina Chougui, Florence Margottin-Goguet · 2019 · Frontiers in Microbiology
13. Proviral DNA as a Target for HIV-1 Resistance Analysis
    Nadine Lübke, Veronica Di Cristanziano, Saleta Sierra, Elena Knops, Eugen Schülter, Björn Jensen, Mark Oette, Thomas Lengauer, Rolf Kaiser, on behalf of the Resina Study Group · 2015 · Intervirology
14. HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
    María Rosa López‐Huertas, Claudia Palladino, M.G. Arquero, Beatriz Esteban-Cartelle, Marta Sánchez-Carrillo, Paula Martínez-Román, Luz Martín‐Carbonero, Pablo Ryan, Lourdes Domínguez, Ignacio de los Santos et al. · 2019 · Scientific Reports
15. HIV-1 Latency and Latency Reversal: Does Subtype Matter?
    Indra Sarabia, Alberto Bosque · 2019 · Viruses
16. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure
    Hongping Jin, Dongsheng Li, Min‐Hsuan Lin, Li Li, David Harrich · 2020 · Viruses
17. The HIV-1 latent reservoir is largely sensitive to circulating T cells
    Joanna A Warren, Shuntai Zhou, Yinyan Xu, Matthew Moeser, Daniel MacMillan, Jennifer Kirchherr, Julia Sung, Nadia R. Roan, Adaora A. Adimora, Sarah Joseph et al. · 2020 · eLife
18. Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques
    Ashish Goyal, Elizabeth R. Duke, Erwing Fabian Cardozo Ojeda, Joshua Tisdell Schiffer · 2022 · iScience
19. Structural Basis for the Interaction of CCR5 with a Small Molecule, Functionally Selective CCR5 Agonist
    Yuji Saita, Eiichi N. Kodama, Masaya Orita, Mitsuhiro Kondo, Takahiro Miyazaki, Kenji Sudo, Keiko Kajiwara, Masao Matsuoka, Yasuaki Shimizu · 2006 · The Journal of Immunology
20. HIV Quasispecies Dynamics during Pro-Active Treatment Switching: Impact on Multi-Drug Resistance and Resistance Archiving in Latent Reservoirs
    Max von Kleist, Stephan Menz, Hartmut Stocker, Keikawus Arastéh, Christof Schütte, Wilhelm Huisinga · 2011 · PLoS ONE
21. Underlying mechanisms of HIV-1 latency
    Bizhan Romani, Elham Allahbakhshi · 2017 · Virus Genes
22. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
    Cecilia Sgadari, Paolo Monini, Antonella Tripiciano, Orietta Picconi, Anna Casabianca, Chiara Orlandi, Sonia Moretti, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia et al. · 2019 · Frontiers in Immunology
23. Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance
    Liu, Jian, Kelly, Joseph, Yu, Wensheng, Clausen, Dane, Yu, Younong, Kim, Hyunjin, Duffy, Joseph L., Chung, Christine C., Myers, Robert W., Carroll, Steve et al. · 2020 · ACS Medicinal Chemistry Letters
24. Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir
    Pavitra Roychoudhury, Harshana S. De Silva Feelixge, Daniel B. Reeves, Bryan T. Mayer, Daniel Stone, Joshua Tisdell Schiffer, Keith R. Jerome · 2018 · BMC Biology
25. CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
    Amanda R. Panfil, James A. London, Patrick L. Green, Kristine E. Yoder · 2018 · Frontiers in Microbiology
26. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection
    Samuel Long, Christine M. Fennessey, Laura P. Newman, Carolyn Reid, Sean P. O’Brien, Yuan Li, Gregory Q. Del Prete, Jeffrey D. Lifson, Robert J. Gorelick, Brandon F. Keele · 2019 · Journal of Virology
27. Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection
    Rajat Desikan, Rubesh Raja, Narendra M. Dixit · 2020 · PLoS Computational Biology
28. CD8 Lymphocyte Depletion Enhances the Latency Reversal Activity of the SMAC Mimetic AZD5582 in ART-Suppressed Simian Immunodeficiency Virus-Infected Rhesus Macaques
    Maud Mavigner, Laura E. Liao, Alyssa D. Brooks, Ruian Ke, Cameron Mattingly, Nils Schoof, Julia Bergild McBrien, Diane G. Carnathan, Shan Liang, Thomas H. Vanderford et al. · 2021 · Journal of Virology
29. The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
    Yang-Hui Jimmy Yeh, Kerui Yang, Anya Razmi, Ya‐Chi Ho · 2021 · Viruses
30. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice
    Mathieu Amand, Philipp Adams, Rafaëla Schober, Gilles Iserentant, Jean-Yves Servais, Michel P. Moutschen, Carole Seguin‐Devaux · 2023 · eLife
31. A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells
    Jackson J. Peterson, Catherine A. Lewis, Samuel D. Burgos, Manickam Ashokkumar, Yinyan Xu, Allison A Rowley, Genevieve Clutton, Brian Richardson, Fei Zou, Jeremy M. Simon et al. · 2023 · Cell chemical biology
32. Epigenetics of HIV infection: promising research areas and implications for therapy.
    Éva Áy, Ferenc Bánáti, Mária Mezei, Ágnes Bakos, Hans Helmut Niller, Krisztina Buzás, János Minárovits · 2013 · PubMed
33. Changes in HIV reservoirs during long-term antiretroviral therapy
    Feiyu F. Hong, John W. Mellors · 2014 · Current Opinion in HIV and AIDS
34. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection
    Feng Yun Yue, Jared C. Cohen, Mu Ho, A. K. M. Nur-ur Rahman, Jun Liu, Shariq Mujib, Aamir Saiyed, Sabrina Hundal, Alexandra Khozin, Phil Bonner et al. · 2017 · Journal of Virology
35. HIV Controllers Exhibit Effective CD8+ T Cell Recognition of HIV-1-Infected Non-activated CD4+ T Cells
    Blandine Monel, Annmarie McKeon, Pedro A. Lamothe, Priya Jani, Julie Boucau, Yovana Pacheco, Richard Brad Jones, Sylvie Le Gall, Bruce D. Walker · 2019 · Cell Reports
36. RNA Interference-Based Therapeutics: Molecular Platforms for Infectious Diseases
    Sathish Dyawanapelly, Sharwari Ghodke, Ramya Vishwanathan, Prajakta P. Dandekar, Ratnesh D. Jain · 2014 · Journal of Biomedical Nanotechnology
37. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors
    Riddhima Banga, Francesco A. Procopio, Matthias L. Cavassini, Matthieu Perreau · 2015 · Journal of Virology
38. Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors
    Damodara N. Reddy, Flavio Ballante, Timothy Chuang, Adele Pirolli, Biagina Marrocco, Garland R. Marshall · 2015 · Journal of Medicinal Chemistry
39. Survivors Remorse: antibody‐mediated protection against HIV ‐1
    George K. Lewis, Marzena Pazgier, Anthony L. DeVico · 2017 · Immunological Reviews
40. New challenges in therapeutic vaccines against HIV infection
    Lorna Leal, Constanza Lucero, Josep Maria Gatell, Teresa Gallart, Montserrat Plana, Felipe García · 2017 · Expert Review of Vaccines
41. Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART
    Marcial García, Miguel Górgolas, Alfonso Cabello, Vicente Estrada, Jose Manuel Ligos, Manuel Fernández Guerrero, Carlos Barrós, Juan Carlos López-Bernaldo, Francisco Javier De la Hera, Marı́a C. Montoya et al. · 2017 · Scientific Reports
42. Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
    Gilles Darcis, Atze T. Das, Ben Berkhout · 2018 · Viruses
43. Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics
    Matthew R. Gardner · 2020 · Frontiers in Cellular and Infection Microbiology
44. IP-10 Promotes Latent HIV Infection in Resting Memory CD4+ T Cells via LIMK-Cofilin Pathway
    Zhuo Wang, Xiaowan Yin, Meichen Ma, Hongchi Ge, Bin Lang, Hong Sun, Sijia He, Yajing Fu, Yu Sun, Xiaowen Yu et al. · 2021 · Frontiers in Immunology
45. HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys
    Brian Moldt, Abishek Chandrashekar, Erica N. Borducchi, Joseph P. Nkolola, Heather T. Stephenson, Mark Nagel, Magdeleine Hung, Joshua Goldsmith, Craig S. Pace, Brian Carr et al. · 2022 · PLoS Pathogens
46. Assays to Measure Latency, Reservoirs, and Reactivation
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2017 · Current topics in microbiology and immunology
47. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda
    Jessica L. Prodger, Jun Lai, Steven James Reynolds, Jeanne C. Keruly, Richard D. Moore, Jingo Kasule, Taddeo Kityamuweesi, Paul Buule, David Serwadda, Martha Nason et al. · 2017 · Clinical Infectious Diseases
48. CD8+ lymphocyte control of SIV infection during antiretroviral therapy
    Youfang Cao, Emily Kathleen Cartwright, Guido Silvestri, Alan S. Perelson · 2018 · PLoS Pathogens
49. CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART
    Cheng-Bo Song, Lele Zhang, Xian Wu, Yajing Fu, Yongjun Jiang, Hong Shang, Zining Zhang · 2020 · Journal of Translational Medicine
50. HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells
    Giancarlo Marone, Francesca Wanda Rossi, Antonio Pecoraro, Valentina Pucino, Gjada Criscuolo, Amato de Paulis, Giuseppe Spadaro, Gianni Marone, Gilda Varricchi · 2020 · Vaccines
51. Haemopoietic cell transplantation in patients living with HIV
    Richard F. Ambinder, Adam A. Capoferri, Christine M. Durand · 2020 · The Lancet HIV
52. HIV Gene Therapy: An Update
    Tatjana I. Cornu, Claudio Mussolino, Matthias C. Müller, Claudia Wehr, Winfried V. Kern, Toni Cathomen · 2020 · Human Gene Therapy
53. Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure
    Edrous Alamer, Chaojie Zhong, Renee L. Hajnik, Lynn Soong, Haitao Hu · 2021 · Retrovirology
54. Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy
    Yuqi Zhou, Colby R. Maldini, Julie K. Jadlowsky, James L. Riley · 2020 · The Journal of Infectious Diseases
55. HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies
    Shilpa Sonti, Adhikarimayum Lakhikumar Sharma, Mudit Tyagi · 2021 · Virus Research
56. Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4 + T Cells
    Lok Yan Yim, Ka Shing Lam, Tsz‐Yat Luk, Yufei Mo, Xiaofan Lu, Jinlin Wang, Ka‐Wai Cheung, Grace Chung-Yan Lui, Denise Pui Chung Chan, Bonnie Chun Kwan Wong et al. · 2023 · Journal of Virology
57. The Psychology of AIDS Denialism
    Seth C. Kalichman · 2014 · European Psychologist
58. Targeting IκB Proteins for HIV Latency Activation: the Role of Individual IκB and NF-κB Proteins
    Guerau Fernández, Thomas D. Zaikos, Sohrab Zafar Khan, Ashley M. Jacobi, Mark A. Behlke, Steven L. Zeichner · 2013 · Journal of Virology
59. FIV as a Model for HIV: An Overview
    Ellen E. Sparger · 2007 · Springer eBooks
60. Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children
    Katherine Luzuriaga · 2016 · Annual Review of Medicine
61. Evaluation of the in vitro antiretroviral potential of some Biginelli-type pyrimidines
    Rezvan Zabihollahi, Rouhollah Vahabpour, Christine Hartoonian, Bita Sedaghati, Seyed Mehdi Sadat, Mousa Soleymani, Maryam Ranjbar, Afshin Fassihi, Mohammad Reza Aghasadeghi, Hamid Reza Memarian et al. · 2012 · Acta Virologica
62. The Alphabet Soup of HIV Reservoir Markers
    Radwa Sharaf, Jonathan Z. Li · 2017 · Current HIV/AIDS Reports
63. Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir
    Bingfeng Liu, Wanying Zhang, Hui Zhang · 2019 · Current Opinion in Virology
64. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4 ⁺ T Cell Subsets during Long-Term Combination Antiretroviral Therapy
    Jones, Bradley R., Miller, Rachel L., Kinloch, Natalie N., Tsai, Olivia, Rigsby, Hawley, Sudderuddin, Hanwei, Shahid, Aniqa, Ganase, Bruce, Brumme, Chanson J., Harris, Marianne et al. · 2020 · Journal of Virology
65. Gene expression and chromatin conformation of microglia in virally suppressed people with HIV
    Johannes C. M. Schlachetzki, Sara Gianella, Zhengyu Ouyang, Addison J. Lana, Xiaoxu Yang, Sydney O’Brien, Jean F. Challacombe, Peter J. Gaskill, Kelly L. Jordan‐Sciutto, Antoine Chaillon et al. · 2024 · Life Science Alliance
66. Dynamics of the HIV infection under antiretroviral therapy: A cellular automata approach
    Ramón E.R. González, S. Coutinho, Rita Maria Zorzenon dos Santos, Pedro Hugo de Figueirêdo · 2013 · Physica A Statistical Mechanics and its Applications
67. Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction
    Mario Ostrowski, Erika Benko, Feng Yun Yue, Connie J. Kim, Sanja Huibner, Terry Lee, Joel Singer, Jim Pankovich, Oliver B Laeyendecker, Rupert Kaul et al. · 2015 · Open Forum Infectious Diseases
68. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV
    Mary-Aude Rochat, Erika Schlaepfer, Roberto F. Speck · 2016 · Journal of Virology
69. Clonal Expansion of Human Immunodeficiency Virus–Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy
    James I. Mullins, Lisa M. Frenkel · 2017 · The Journal of Infectious Diseases
70. Peering into the HIV reservoir
    Marcial García, Maria José Buzón, Jose Miguel Benito, Norma Ibón Rallón · 2018 · Reviews in Medical Virology
71. Versatile iron–catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy
    Rubén Solórzano, Olivia Tort, Javier García‐Pardo, Tuixent Escribà, Júlia Lorenzo, Mireia Arnedo, Daniel Ruiz‐Molina, Ramón Alibés, Félix Busquè, Fernando Novio · 2018 · Biomaterials Science
72. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1 + and TIGIT + CD4 T Cells
    George N. Llewellyn, Eduardo Seclén, Stephen W. Wietgrefe, Siyu Liu, Morgan Chateau, Hua Pei, Katherine Perkey, Matthew D. Marsden, Sarah J. Hinkley, David E. Paschon et al. · 2019 · Journal of Virology
73. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
    Alex Olson, Binita Basukala, Seunghee Lee, Matthew Gagné, Wilson W. Wong, Andrew J. Henderson · 2020 · Viruses
74. Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients
    Romain Palich, Elisa Teyssou, Sophie Sayon, Basma Abdi, Cathia Soulié, Lise Cuzin, Roland Tubiana, Marc‐Antoine Valantin, Luminita Schneider, Sophie Seang et al. · 2021 · The Journal of Infectious Diseases
75. Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases
    Xiaofei Chen, Xin Zhao, Zifeng Yang · 2021 · Journal of Medicinal Chemistry
76. Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence
    Daniel B. Reeves, Charline Bacchus, Mark D. Fitch, Mohamed Abdel‐Mohsen, Rebecca Hoh, Haelee Ahn, Mars Stone, Frederick M. Hecht, Jeffrey N. Martin, Steven G. Deeks et al. · 2023 · Nature Communications
77. HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy
    Hans S.L.M. Nottet, Sabine J. van Dijk, Ewout B. Fanoy, Irma W Goedegebuure, Dorien C. M. de Jong, Nienke Vrisekoop, Debbie van Baarle, Valerie F. Boltz, Sarah Palmer, Jan C.C. Borleffs et al. · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
78. Controversies in HIV cure research
    Rowena Johnston, Françoise Barré‐Sinoussi · 2012 · Journal of the International AIDS Society
79. Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy
    Anthony Richard Cillo, Supriya Krishnan, Deborah K. McMahon, Ronald T. Mitsuyasu, Michael F. Para, John W. Mellors · 2014 · PLoS ONE
80. A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes
    Zaohua Huang, Madahavan Nair · 2017 · Scientific Reports
81. Therapy of HIV Infection: Current Approaches and Prospects
    Maria M. Prokofjeva, Sergey N. Kochetkov, Vladimir Prassolov · 2016 · Acta Naturae
82. Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors
    Maxime Junior Jean, Guillaume N. Fiches, Tsuyoshi Hayashi, Jian Kang Zhu · 2018 · AIDS Research and Human Retroviruses
83. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection
    Adit Dhummakupt, Jessica H. Rubens, Thuy Anderson, Laura Powell, Bareng A. S. Nonyane, Lilly Siems, Aleisha N. Collinson-Streng, Tricia L. Nilles, Richard Brad Jones, Vicki J. Tepper et al. · 2020 · JCI Insight
84. DNA cleavage enzymes for treatment of persistent viral infections: Recent advances and the pathway forward
    Nicholas D. Weber, Martine Aubert, Chung H. Dang, Daniel Stone, Keith R. Jerome · 2014 · Virology
85. In vivo platforms for analysis of HIV persistence and eradication
    J. Víctor García · 2016 · Journal of Clinical Investigation
86. Anti-HIV-1 antibody-dependent cellular cytotoxicity
    Wen Shi Lee, Stephen John Kent · 2017 · Current Opinion in HIV and AIDS
87. CBF-1 Promotes the Establishment and Maintenance of HIV Latency by Recruiting Polycomb Repressive Complexes, PRC1 and PRC2, at HIV LTR
    Mudit Tyagi, Sonia Zicari, Shilpa Sonti, Sonia Zicari, Lin Sun, Aseel Alqatawni, Michael Bukrinsky, Gary Leonard Simon, Ashok Chauhan, René Daniel et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
88. Long non-coding RNAs and latent HIV – A search for novel targets for latency reversal
    Wim Trypsteen, Cory White, Amey Mukim, Celsa A. Spina, Ward De Spiegelaere, Steve Lefever, Vicente Planelles, Alberto Bosque, Christopher H. Woelk, Linos Vandekerckhove et al. · 2019 · PLoS ONE
89. Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
    Jeffrey C. Umotoy, Steven W. de Taeye · 2021 · Frontiers in Immunology
90. Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes
    Katie Fisher, Xiao Qian Wang, Ashley Lee, Vincent Morcilla, Anneke de Vries, Eunok Lee, John‐Sebastian Eden, Steven G. Deeks, Anthony Dominic Kelleher, Sarah Palmer · 2022 · Journal of Virology
91. New insights into transcription elongation control of HIV-1 latency and rebound
    Uri R. Mbonye, Fredrick Kizito, Jonathan Karn · 2022 · Trends in Immunology
92. Macroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages
    Sophie Borel, Lucile Espert, Martine Biard‐Piechaczyk · 2012 · Frontiers in Immunology
93. Keeping quiet: microRNAs in HIV-1 latency
    Yefei Han, Robert F. Siliciano · 2007 · Nature Medicine
94. Quantification of viral DNA during HIV-1 infection: A review of relevant clinical uses and laboratory methods
    Enagnon Kazali Alidjinou, Laurence Bocket, Didier Hober · 2014 · Pathologie Biologie
95. Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis
    Janet Patricia Hapgood, Michele Tomasicchio · 2010 · Archives of Virology
96. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART
    Cathia Soulié, Anne‐Geneviève Marcelin, Jade Ghosn, Bahia Amellal, Lambert Assoumou, Sidonie Lambert-Niclot, Claudine Duvivier, Dominique G. Costagliola, Christine Katlama, Vincent Cálvez · 2007 · AIDS
97. Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter
    Renée Marije van der Sluis, Georgios Pollakis, Marja L van Gerven, Ben Berkhout, Rienk E. Jeeninga · 2011 · Retrovirology
98. Potential Implication of Residual Viremia in Patients on Effective Antiretroviral Therapy
    Gautam Kumar Sahu · 2014 · AIDS Research and Human Retroviruses
99. Quantitation of integrated proviral DNA in viral reservoirs
    Erin H. Graf, Una O’Doherty · 2013 · Current Opinion in HIV and AIDS
100. Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate–Dependent Mechanisms in Humanized Mice In Vivo
     Guangming Li, Jun-ichi Nunoya, Liang Cheng, Natalia Reszka-Blanco, Li-Chung Tsao, Jerry Jeffrey, Lishan Su · 2017 · The Journal of Infectious Diseases